Matthew W. Foehr - 01 Nov 2022 Form 4 Insider Report for OmniAb, Inc. (OABI)

Role: President & CEO, Director
Signature: /s/ Charles S. Berkman, Attorney-in-Fact
Issuer symbol: OABI
Transactions as of: 01 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2022, 21:10:55 UTC
Previous filing: 30 Sep 2022
Next filing: 09 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OABI	Common Stock	Award		+1,305,350			1,305,350	01 Nov 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OABI	Stock Option	Award		+270,595			270,595	01 Nov 2022	Common Stock	270,595	$8.54	Direct	F1, F4
transaction	OABI	Stock Option	Award		+172,768			172,768	01 Nov 2022	Common Stock	172,768	$6.46	Direct	F1, F4
transaction	OABI	Stock Option	Award		+111,038			111,038	01 Nov 2022	Common Stock	111,038	$9.84	Direct	F1, F4
transaction	OABI	Stock Option	Award		+104,231			104,231	01 Nov 2022	Common Stock	104,231	$11.52	Direct	F1, F4
transaction	OABI	Stock Option	Award		+86,790			86,790	01 Nov 2022	Common Stock	86,790	$18.24	Direct	F1, F4
transaction	OABI	Stock Option	Award		+146,325			146,325	01 Nov 2022	Common Stock	146,325	$13.54	Direct	F1, F5
transaction	OABI	Stock Option	Award		+142,168			142,168	01 Nov 2022	Common Stock	142,168	$10.98	Direct	F1, F6
transaction	OABI	Stock Option	Award		+56,233			56,233	01 Nov 2022	Common Stock	56,233	$20.36	Direct	F1, F7
transaction	OABI	Stock Option	Award		+298,311			298,311	01 Nov 2022	Common Stock	298,311	$10.41	Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.
F2	Includes 176,076 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.
F3	Includes 264,760 earn-out shares subject to forfeiture provisions described in the Merger Agreement.
F4	The stock option is fully vested and exercisable.
F5	The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter.
F6	The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter.
F7	The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter.
F8	The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.